We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 1.32% | 3.85 | 3.70 | 4.00 | 3.85 | 3.80 | 3.80 | 132,766 | 08:04:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 3.19M | -6.49M | -0.0122 | -3.20 | 20.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/11/2024 09:48 | I prefer to focus purely on annual revenues and a healthy dose of pessimistic realism as to what else might come in to tickle our fancy. I am mildly disappointed (especially on US sales) but on the plus side revenues are still growing ahead of the big boosters to come of Ecovelex, Powdery Mildew and the insecticide. | money never sleeps | |
07/11/2024 09:42 | How does that reconcile with exciting ? | alchemy | |
07/11/2024 09:30 | I anticipate that The Vikings will give Eden's face a thorough scrub. | supersonico | |
07/11/2024 09:10 | Just to add that my investment thesis is that Eden really just needs to wash its face on existing product sales until the other big announcements land in Q4 '24 and 2025. I would like to know how much was spent on the regulatory renewal process this year , which has obviously increased costs on a one off basis | money never sleeps | |
07/11/2024 09:09 | A fundraise is not off the cards and I have said it here myself. And really that does not matter so much as knowing at what price - if the good news expected materialises between now and end of 2025, there may be no need for a fundraise except perhaps to propel future expansion, for example, with the insecticide product though again. I would expect those costs to be borne mainly by the chosen partner/ distributor in the normal way. It is more than reasonable to expect a milestone payment at the time of announcement. | money never sleeps | |
07/11/2024 09:05 | Bad Guess. You call me what ever you like if that helps. You could also come up with your own ideas rather than imitating ..that would be welcome and novel. | supersonico | |
07/11/2024 08:54 | OK, maybe we should call you subsonic or super slowly, because the share price has fallen 60% since the last pump and dump raise. Next step below 3p. Great investment. Congrats to all long term holders. | ravenna23 | |
07/11/2024 08:36 | The cynical use of the word currently in "the company does not "currently" expect to raise" makes it likely they will raise, especially with losses increasing. | mr macgregor | |
07/11/2024 08:32 | Best Guess, Considering your track record of poor comprehension I'm thinking it's time to formally change your name to Bad Guess. | supersonico | |
07/11/2024 08:30 | Read it right, another cap raise very soon, and this time the AIM funds will be wise to the Eden hoax | ravenna23 | |
07/11/2024 08:12 | Two excellent RNS’ today. | kittybiscuits | |
07/11/2024 07:36 | Viking watch. 'To make it possible for us to perceive and to comprehend things invisible, we are forced to conceptualize objects whose existence cannot be independently verified but can only be inferred from their observable influences similarly to the way physicists infer the existence of subatomic particles. ' Orlov 2024 No Sightings today but the 'outlook' commentary of 'EU-wide approval of Ecovelex' on it's timetable 2025+ 'Very soon' anticipated arrival was noted. | supersonico | |
07/11/2024 07:15 | Inthecoming- Trading Update Ecovelex Approval in Italy | supersonico | |
07/11/2024 06:57 | Thanks for the reply. My impression is that Eden are looking at Bio-stimulants in some form unrelated to PHC . | supersonico | |
06/11/2024 22:51 | I was following your lead on Biostimulants. Plant Health Care was active in that market. It has been acquired for a value which provides a useful benchmark for the value of Eden's current business. Eden does not make Biostimulant products. It uses terpenes which are a plant's natural defence mechanism. The new products you are referring to may have been developed out of IP originally developed by PHC | money never sleeps | |
06/11/2024 20:53 | That's a curious answer..@19095 Plus I have no clue what the relevance Plant Health Care is @19096. More curiousness. Please expand Money never sleeps - 04 Nov 2024 - 08:28:36 - 19053 of 19135 Eden Research - EDEN That's a bit far-fetched IMO | supersonico | |
06/11/2024 20:52 | Plant Health Care (Biostimulants), now a wholly owned subsidiary of PI Industries Ltd of India. hxxps://www.planthea | money never sleeps | |
06/11/2024 20:04 | In a word, no. | money never sleeps | |
06/11/2024 19:40 | Question. Is Eden's yet to be announced second seed treatment a Syngenta Biostimulant? | supersonico | |
06/11/2024 19:27 | A biostimulant is any substance or microorganism applied to plants, seeds, or the root environment to stimulate plants’ natural processes. Benefiting nutrient use, efficiency and tolerance to abiotic stress, regardless of its nutrient content or any combination of such substances and/or microorganisms intended for this use. The global biostimulant market is growing rapidly, with a projected value of $8,004.10 million by 2031. Biostimulants are biologically produced fertilizers used to stimulate plant development and productivity1. The market is driven by increasing demand for biostimulants in various end-use applications such as seed, soil, and foliar treatment. | supersonico | |
06/11/2024 18:59 | Question. Which of Eden's pipeline products could be considered a Bio-Stimulant?? | supersonico | |
06/11/2024 17:31 | It's just a four year hold Neuts .... | timbo_slice | |
06/11/2024 16:54 | We'll be at Booth 217 at the 50th Annual Conference & Agri-Expo South, CAPCA, this coming weekend! We'd love to meet you and introduce you to products you may already know and our great new products, Mevalone and Annuity. | supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions